A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1 - PubMed (original) (raw)

A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1

H M Temin. Proc Natl Acad Sci U S A. 1993.

Abstract

Human immunodeficiency virus type 1 (HIV-1) is a more complex retrovirus, coding for several accessory proteins in addition to the structural proteins (Gag, Pol, and Env) that are found in all retroviruses. More complex retroviruses have not been isolated from birds, and simpler retroviruses have not been isolated from humans. However, the proviruses of many endogenous simpler retroviruses are present in the human genome. These observations suggest that humans can mount a successful protective response against simpler retroviruses, whereas birds cannot. Thus, humans might be able to mount a successful protective response to infection with a simpler HIV-1. As a model, a simpler bovine leukemia virus which is capable of replicating has been constructed; a simpler HIV-1 could be constructed in a similar fashion. I suggest that such a simpler HIV-1 would be a safe and effective vaccine against HIV-1.

PubMed Disclaimer

Similar articles

• Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
  Smith JM, Amara RR, McClure HM, Patel M, Sharma S, Yi H, Chennareddi L, Herndon JG, Butera ST, Heneine W, Ellenberger DL, Parekh B, Earl PL, Wyatt LS, Moss B, Robinson HL. Smith JM, et al. AIDS Res Hum Retroviruses. 2004 Jun;20(6):654-65. doi: 10.1089/0889222041217419. AIDS Res Hum Retroviruses. 2004. PMID: 15242543
• Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.
  Wyatt LS, Earl PL, Liu JY, Smith JM, Montefiori DC, Robinson HL, Moss B. Wyatt LS, et al. AIDS Res Hum Retroviruses. 2004 Jun;20(6):645-53. doi: 10.1089/0889222041217428. AIDS Res Hum Retroviruses. 2004. PMID: 15242542
• DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.
  Smith JM, Amara RR, Campbell D, Xu Y, Patel M, Sharma S, Butera ST, Ellenberger DL, Yi H, Chennareddi L, Herndon JG, Wyatt LS, Montefiori D, Moss B, McClure HM, Robinson HL. Smith JM, et al. AIDS Res Hum Retroviruses. 2004 Dec;20(12):1335-47. doi: 10.1089/aid.2004.20.1335. AIDS Res Hum Retroviruses. 2004. PMID: 15650426
• Molecular biology of type A endogenous retrovirus.
  Ono M. Ono M. Kitasato Arch Exp Med. 1990 Sep;63(2-3):77-90. Kitasato Arch Exp Med. 1990. PMID: 1710682 Review.
• Retroviruses and autoimmunity.
  Sekigawa I, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. Sekigawa I, et al. Intern Med. 2001 Feb;40(2):80-6. doi: 10.2169/internalmedicine.40.80. Intern Med. 2001. PMID: 11300167 Review.

Cited by

• Modification of the Spike Protein for Vaccines against Enveloped RNA Viruses.
  Vzorov AN, Samokhvalov EI, Chebanenko VV, Scheblyakov DV, Gintsburg AL. Vzorov AN, et al. Mol Biol. 2021;55(4):538-547. doi: 10.1134/S0026893321030158. Epub 2021 Aug 26. Mol Biol. 2021. PMID: 34465926 Free PMC article.
• Genetic analysis of HIV-1 subtypes in Nairobi, Kenya.
  Khoja S, Ojwang P, Khan S, Okinda N, Harania R, Ali S. Khoja S, et al. PLoS One. 2008 Sep 11;3(9):e3191. doi: 10.1371/journal.pone.0003191. PLoS One. 2008. PMID: 18784834 Free PMC article.
• Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits.
  Altanerova V, Holicova D, Kucerova L, Altaner C, Lairmore MD, Boris-Lawrie K. Altanerova V, et al. Virology. 2004 Nov 24;329(2):434-9. doi: 10.1016/j.virol.2004.09.001. Virology. 2004. PMID: 15518821 Free PMC article.
• The IDDM-associated solitary retroviral promoters DQ-LTR3 and DQ-LTR13 have a distinct impact on the expression of selected DQB1 genes in different cell lines in vitro.
  Krach K, Badenhoop K, Tönjes RR. Krach K, et al. Immunogenetics. 2003 Nov;55(8):521-9. doi: 10.1007/s00251-003-0614-5. Epub 2003 Oct 18. Immunogenetics. 2003. PMID: 14566435
• Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.
  Guan Y, Whitney JB, Detorio M, Wainberg MA. Guan Y, et al. J Virol. 2001 May;75(9):4056-67. doi: 10.1128/JVI.75.9.4056-4067.2001. J Virol. 2001. PMID: 11287555 Free PMC article.

References

1. 1. Nature. 1975 Oct 16;257(5527):612-4 - PubMed
2. 1. Science. 1992 Dec 18;258(5090):1938-41 - PubMed
3. 1. J Virol. 1985 Jun;54(3):764-72 - PubMed
4. 1. Science. 1985 Jun 7;228(4704):1208-11 - PubMed
5. 1. J Virol. 1987 Dec;61(12):4060-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program